Evidence map›Paper›PMID 33389959›Full record

ArticleDiabetes & metabolism journal2020

Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea.

Sung-Youn Chun, Dong Wook Kim, Sang Ah Lee, Su Jung Lee, Jung Hyun Chang, Yoon Jung Choi, Seong Woo Kim, Sun Ok Song

Open access · goldAbstract read
In one paragraph

Article in Diabetes & metabolism journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sung-Youn ChunResearch and Analysis Team, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Dong Wook KimDepartment of Big Data, National Health Insurance Service, Wonju, Korea.
Sang Ah LeeResearch and Analysis Team, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Su Jung LeeResearch Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Jung Hyun ChangResearch Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Yoon Jung ChoiResearch Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Seong Woo KimResearch Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Sun Ok SongResearch Institute of National Health Insurance Service Ilsan Hospital, Goyang, Korea.
National Health Insurance Service Ilsan Hospital · KRNational Health Insurance Service · KR

Funding

National Health Insurance Service Ilsan Hospital NHIMC-2020C-R007
6 · The paper itself

Abstract

backgroundThis study aimed to determine the infection risk of coronavirus disease 2019 (COVID-19) in patients with diabetes (according to treatment method).

methodsClaimed subjects to the Korean National Health Insurance claims database diagnosed with COVID-19 were included. Ten thousand sixty-nine patients with COVID-19 between January 28 and April 5, 2020, were included. Stratified random sampling of 1:5 was used to select the control group of COVID-19 patients. In total 50,587 subjects were selected as the control group. After deleting the missing values, 60,656 subjects were included.

resultsAdjusted odds ratio (OR) indicated that diabetic insulin users had a higher risk of COVID-19 than subjects without diabetes (OR, 1.25; 95% confidence interval [CI], 1.03 to 1.53; P=0.0278). In the subgroup analysis, infection risk was higher among diabetes male insulin users (OR, 1.42; 95% CI, 1.07 to 1.89), those between 40 and 59 years (OR, 1.66; 95% CI, 1.13 to 2.44). The infection risk was higher in diabetic insulin users with 2 to 4 years of morbidity (OR, 1.744; 95% CI, 1.003 to 3.044).

conclusionSome diabetic patients with certain conditions would be associated with a higher risk of acquiring COVID-19, highlighting their need for special attention. Efforts are warranted to ensure that diabetic patients have minimal exposure to the virus. It is important to establish proactive care and screening tests for diabetic patients suspected with COVID-19 for timely disease diagnosis and management.

Indexed as

Population SurveillanceSocial ClassAdolescentAdultAgedAged, 80 and overCOVID-19Databases, FactualDiabetes MellitusFemaleHumansMaleMiddle AgedNational Health ProgramsRepublic of KoreaRisk FactorsCOVID-19Diabetes mellitusIncidence

Identifiers

PMID33389959
PMCPMC7801768
OpenAlexW3113908518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.